Navigation Links
InVitria Reveals Technology to Optimize Hybridoma Production Performance
Date:4/27/2009

Fort Collins, CO April 27, 2009 / b3c newswire / – Recent studies using both classical media and the leading commercial serum-free hybridoma media formulations proved that InVitria’s cell culture supplements optimized cell growth and productivity of hybridoma cells. 1 Further, the studies revealed that Cellastim supports cell adaptation and survival in chemically-defined media.

Additional findings from the study showed that Cellastim improved the cell growth and productivity in long-term culture. In a 25-day period, cell doublings in Cellastim-supplemented media were twice that of media without Cellastim. Also, antibody production was 65% higher in the commercial media with Cellastim while cells supplemented with Cellastim grew to higher density than those in unsupplemented media.

“This research incorporated classical media as well as several leading commercial media available on the market,” said Dr. Steve Pettit, the project’s lead researcher. “We achieved optimal cell density and quicker doubling times as well as better cell productivity when Cellastim was added to these media. We also reported that Lacromin improves hybridoma cell culture performance.”

Lacromin increased cell density in supplemented media nearly double compared to that of media without Lacromin supplementation. A significant increase in antibody production was recognized in all Lacromin-treated media, exceeding the level achieved with 5% fetal bovine serum (FBS).

 “This research supports what customers have been reporting from their use of Cellastim and Lacromin for hybridoma cell culture,” said InVitria President and CEO Scott Deeter. “Cellastim has been shown to not only optimize hybridoma performance, but also outperform other sources of native and recombinant albumin.”

To obtain a copy of the above-mentioned article entitled, “Enhanced Growth and Productivity of a Hybridoma with Recombinant Human Albumin and Lactoferrin,” please contact InVitria at info@InVitria.com or 1-800-916-8311.


About InVitria - www.InVitria.com
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture products and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research and diagnostics.


Contact

Erik H. Vogel
InVitria
Marketing Manager
Phone: 1-800-916-8311
www.InVitria.com

----------------------------------------------------------------------------------
1 Pettit S, Santos M, Tanner T, Huang N. Enhanced Growth and Productivity of a Hybridoma with Recombinant Human Albumin and Lactoferrin. BioProcessing Journal 2009; 8(1): 50-55. 


'/>"/>
b3c newswire

Related biology technology :

1. InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication
2. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
3. InVitrias Cellastim Delivers Superior Results in Mammalian Cell Culture
4. InVitria Touts Product Advantages at Cambridges Cell Culture Conference
5. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
6. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
7. InVitria Expands Sales Team
8. InVitrias Animal Free Lacromin(TM) Provides a Cost-Effective Improvement Over Transferrin
9. Proteomics Study Reveals That Genes Involved in Invertebrate Longevity Have Surprising Parallels in Humans.
10. New imaging technique reveals the atomic structure of nanocrystals
11. Mouse study reveals genetic component of empathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ANGELES, CA (PRWEB) , ... February 22, 2017 ... ... today announced that is has acquired Kendall Research Systems, LLC (KRS) ... Technology (MIT) that develops neural interface technology for research and clinical applications. The ...
(Date:2/22/2017)... 22, 2017 Scientists propose in Nature ... damage in Gaucher and maybe other lysosomal storage diseases ... costs than current therapies. An international research ... , which also included investigators from the University of ... data Feb. 22. The study was conducted in mouse ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... tech innovators, engineers, and scientists from around the world, is pleased to announce ... February 22 and 23, 2017. This premier, online-only conference focused on the development ...
(Date:2/22/2017)... 2017 Origin (Origin Agritech, LLC, a subsidiary of Origin ... and Arcadia (Arcadia Biosciences, Inc., NASDAQ: RKDA), ... agricultural productivity traits and nutritional products, today announced their collaboration to ... in China to the United ... ...
Breaking Biology Technology:
(Date:1/26/2017)... CITY , Jan. 26, 2017  Crossmatch, a ... unveiled a new solution aimed at combatting fraud, waste ... solution was introduced at the Action on Disaster Relief ... key meeting point for UN agencies and foreign assistance ... Fraud, waste and abuse are a largely unacknowledged ...
(Date:1/25/2017)... , Jan. 25, 2017 The Elements of ... (IAM) lifecycle is comprised of a comprehensive set ... purpose of maintaining digital identities and providing a ... applications. There are significant number of programs opted ... to time by optimizing processes and changing policies. ...
(Date:1/24/2017)... Jan. 24, 2017  It sounds simple and ... that monitors vital signs and alerts parents on ... oxygen saturation level drops. But pediatric experts argue ... parents, with no evidence of medical benefits, especially ... marketed aggressively to parents of healthy babies, promising ...
Breaking Biology News(10 mins):